Pinetree Therapeutics
PrivateLast Round
Series B
Oct 28, 2025
Est. Valuation
$135M
Total Funding Raised
$87.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pinetree Therapeutics is a biotechnology company developing transformative therapies through targeted protein degradation for oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinetree Therapeutics Comparables
Compare Pinetree Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EpiBiologics | 85% | |
| Lycia Therapeutics | 84% | |
| Avilar Therapeutics | 79% |
Pinetree Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 28, 2025 | ||||
| Series A Extension | Jul 30, 2024 | ||||
| Series A | Jun 7, 2022 |
Pinetree Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series A |
| SV Investment | Series B |
| DSC Investment | Series B, Series A, Series A Extension |
| Smilegate Investment | Series B |
| STIC Investments | Series A Extension |
| Korea Investment Partners | Series B |
| S&S Investment | Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 65% MoM, reaching 2.9K.
- Jun 17, 2026
Monthly visitors increased 49% MoM.
Pinetree Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pinetree Therapeutics's valuation, stock price, and market status.
Is Pinetree Therapeutics a public or private company?
Pinetree Therapeutics is a private company.
What is the current stock price of Pinetree Therapeutics?
Pinetree Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Pinetree Therapeutics worth (valuation)?
Valuation information for Pinetree Therapeutics is not publicly available.
Can I buy Pinetree Therapeutics stock?
Pinetree Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pinetree Therapeutics's last funding round?
Pinetree Therapeutics's most recent funding round was Series B on October 28, 2025.
Who are the main investors in Pinetree Therapeutics?
Key investors in Pinetree Therapeutics include SV Investment, DSC Investment, Smilegate Investment, S&S Investment, S&S Investment.
Will Pinetree Therapeutics IPO soon?
No public IPO plans have been announced for Pinetree Therapeutics.
How can I track Pinetree Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pinetree Therapeutics's secondary market activity and sign up for updates.